| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,000 | 8,000 | 12.05. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | ABL Diagnostics Reports Historic 2025 Annual Results: Net Income Explosion (+246%), Strong Operating Profitability and Global Acceleration | 230 | Business Wire | Strong revenue growth of +30.4% to €6.95m Positive operating income of €290k, exceeding analyst forecasts Net income soaring to nearly €1m (€987k) International business acceleration:... ► Artikel lesen | |
| Fr | ABL Diagnostics: Availability of the 2025 Annual Financial Report | 308 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that it has made its 2025 Annual Financial Report available to the public and filed it with the Autorité des marchés financiers (AMF).
The... ► Artikel lesen | |
| 17.03. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 320 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 19.02. | ABL Diagnostics S.A.: ABL Diagnostics Update Regarding Non-Binding Letter of Intent | 325 | Business Wire | Regulatory News:
ABL Diagnostics S.A. (Euronext: ABLD ISIN: FR001400AHX6) informs the market that the non-binding Letter of Intent entered into between ProPhase Labs, Inc. and Advanced Biological... ► Artikel lesen | |
| ABL DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 13.02. | ABL Diagnostics SA: ABL SA Executes the First Purchase Notice of ABL Diagnostics Shares With Alumni Capital | 552 | Business Wire | Regulatory News:
ISIN: FR001400AHX6 Euronext Paris
ABL Diagnostics SA ("the Company") (Paris:ABLD) informs the public that its principal shareholder, Advanced Biological Laboratories SA (ABL... ► Artikel lesen | |
| 03.02. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 385 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 19.12.25 | ABL Diagnostics Informs the Market of a Non-Binding Letter of Intent Between ABL S.A. and ProPhase Labs (Nasdaq: PRPH) for a Proposed Reverse Merger | 453 | Business Wire | The contemplated transaction remains subject to due diligence, definitive agreements, regulatory approvals and Nasdaq listing requirements; no change to ABL S.A.'s control over ABL Diagnostics at... ► Artikel lesen | |
| 05.12.25 | ABL Diagnostics S.A.: Information on a Temporary Transfer of ABL Diagnostics Shares | 422 | Business Wire | Regulatory News:
ABL Diagnostics S.A. (ISIN: FR001400AHX6, ticker: ABLD, listed on Euronext Paris) informs its shareholders and the market that a temporary transfer of 128,026 shares of the company... ► Artikel lesen | |
| 14.11.25 | ABL Diagnostics Appoints Eurobio Scientific as Exclusive Distributor for Its VELA Product Line in a Targeted Segment of the French Market | 387 | Business Wire | Regulatory News:
ABL Diagnostics (Euronext Paris: ABLD), a French company specializing in advanced molecular diagnostics, announces the signing of an exclusive distribution agreement with Eurobio... ► Artikel lesen | |
| 22.10.25 | ABL Diagnostics SA: ABL Diagnostics - Announcement of a Second Agreement Between ABL SA and Alumni Capital | 327 | Business Wire | Regulatory News:
ISIN: FR001400AHX6 Euronext Paris
ABL Diagnostics SA (the "Company") (Paris:ABLD) informs the public that Advanced Biological Laboratories SA (ABL SA), its parent company, announced... ► Artikel lesen | |
| 16.10.25 | ABL Diagnostics SA: ABL Diagnostics: Switch to Continuous Trading on Euronext Paris as From November 3rd, 2025 | 406 | Business Wire | Regulatory News:
ABL Diagnostics (Euronext Paris: ABLD ISIN: FR001400AHX6) announces the switch from a fixing-based trading mode to continuous trading as from November 3rd, 2025, in accordance... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 33,900 | +0,98 % | Börse am Morgen: Continental, Henkel, Siemens Healthineers, Konjunkturdaten - Nord/LB | Die deutsche Industrie hat im ersten Monat nach Beginn des Iran-Kriegs überraschend viele Aufträge erhalten. Das Neugeschäft wuchs im März um 5,0% im Vergleich zum Vormonat, wie das Statistische Bundesamt... ► Artikel lesen | |
| THERMO FISHER | 391,40 | +1,90 % | Jim Cramer on Thermo Fisher: "I Think You Can Buy It at This Level" | ||
| STRATEC | 17,180 | -2,39 % | EQS-News: STRATEC SE: STRATEC mit Zahlen für das erste Quartal 2026 | EQS-News: STRATEC SE
/ Schlagwort(e): Quartalsergebnis
STRATEC MIT ZAHLEN FÜR DAS ERSTE QUARTAL 2026
11.05.2026 / 06:55 CET/CEST
Für... ► Artikel lesen | |
| UNIDOC HEALTH | 0,070 | -4,38 % | UniDoc Health Corp.: UniDoc to Update and Relaunch Legacy eHealth Systems with Pawnee Mental Health Services Across Rural Kansas | Ex-AMD Telemedicine account aims to relaunch utilizing UniDoc Connect-enabled eHealth system VANCOUVER, BC / ACCESS Newswire / May 7, 2026 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc"... ► Artikel lesen | |
| DIASORIN | 68,52 | +2,88 % | Milan: DiaSorin on the rise | ||
| BIOCARTIS | - | - | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 21.01.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 21.01.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 21.01.2026ISIN NameBE0974281132 BIOCARTIS... ► Artikel lesen | |
| FRESENIUS | 39,520 | -0,90 % | Börse am Morgen: AMD, Fresenius, Infineon, Renk, Konjunkturdaten - Nord/LB | Die Erzeugerpreise in der Industrie im Euroraum sind mit Beginn des Nahost-Krieges deutlich gestiegen. Im März kletterten sie um 3,4% zum Vormonat. Allein die Energiepreise in der Industrie zogen im... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,660 | +1,05 % | Fresenius Medical Care-Aktie: Jetzt schon einsteigen? | Die Fresenius Medical Care-Aktie befindet sich seit Mai letzten Jahres in einem längerfristigen Abwärtstrend; insgesamt beträgt der Kursrückgang rund -30%. Am Dienstag verliert sie aktuell -4% und steht... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 28,720 | +12,36 % | EQS-AFR: Carl Zeiss Meditec AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Carl Zeiss Meditec AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Carl Zeiss Meditec AG: Vorabbekanntmachung... ► Artikel lesen | |
| WORK MEDICAL TECHNOLOGY GROUP | 7,330 | 0,00 % | WORK Medical Technology Group LTD: WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the "BioToken" Assetization Model | ||
| GERRESHEIMER | 28,400 | +1,21 % | EQS-DD: Gerresheimer AG: AOC Gecko S.à r.l., Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
07.05.2026 / 17:10... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,370 | +7,05 % | S&P Dow Jones Indices: Alignment Healthcare Set to Join S&P SmallCap 600 | NEW YORK, May 11, 2026 /PRNewswire/ -- Alignment Healthcare Inc. (NASD: ALHC) will replace Sun Country Airlines Holdings Inc. (NASD: SNCY) in the S&P SmallCap 600... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 55,48 | +0,74 % | Recent Price Trend in BrightSpring Health Services, Inc. (BTSG) is Your Friend, Here's Why | ||
| HIMS & HERS HEALTH | 21,380 | -13,65 % | Earnings Preview: Nebius, Hims & Hers, Cisco & Co. Welche Zahlen diese Woche spannend werden! | © Foto: Yuki Iwamura - AP/dpa +++ dpa-Bildfunk +++Diese in den kommenden Tagen (KW20) anstehenden US-Quartalszahlen müssen Anlegerinnen und Anleger kennen: Herausforderungen, Erwartungen und die aktuell... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,730 | +8,62 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |